Your browser doesn't support javascript.
loading
Impact of Abstinence and of Reducing Illicit Drug Use Without Abstinence on Human Immunodeficiency Virus Viral Load.
Nance, Robin M; Trejo, Maria Esther Perez; Whitney, Bridget M; Delaney, Joseph A C; Altice, Fredrick L; Beckwith, Curt G; Chander, Geetanjali; Chandler, Redonna; Christopoulous, Katerina; Cunningham, Chinazo; Cunningham, William E; Del Rio, Carlos; Donovan, Dennis; Eron, Joseph J; Fredericksen, Rob J; Kahana, Shoshana; Kitahata, Mari M; Kronmal, Richard; Kuo, Irene; Kurth, Ann; Mathews, W Chris; Mayer, Kenneth H; Moore, Richard D; Mugavero, Michael J; Ouellet, Lawrence J; Quan, Vu M; Saag, Michael S; Simoni, Jane M; Springer, Sandra; Strand, Lauren; Taxman, Faye; Young, Jeremy D; Crane, Heidi M.
Afiliação
  • Nance RM; Department of Biostatistics, University of Washington, Collaborative Health Studies Coordinating Center, Seattle.
  • Trejo MEP; Department of Biostatistics, University of Washington, Collaborative Health Studies Coordinating Center, Seattle.
  • Whitney BM; Department of Biostatistics, University of Washington, Collaborative Health Studies Coordinating Center, Seattle.
  • Delaney JAC; Department of Biostatistics, University of Washington, Collaborative Health Studies Coordinating Center, Seattle.
  • Altice FL; Department of Medicine, Yale University School of Medicine, New Haven, Connecticut.
  • Beckwith CG; Department of Medicine, Alpert Medical School of Brown University, Providence, Rhode Island.
  • Chander G; Division of General Internal Medicine, Johns Hopkins University, Baltimore, Maryland.
  • Chandler R; National Institute on Drug Abuse, Bethesda, Maryland.
  • Christopoulous K; Department of Medicine, University of California-San Francisco.
  • Cunningham C; Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York.
  • Cunningham WE; Department of Medicine, University of California-Los Angeles.
  • Del Rio C; Department of Global Health, Emory University, Atlanta, Georgia.
  • Donovan D; Department of Psychiatry, University of Washington, Seattle.
  • Eron JJ; Department of Medicine, University of North Carolina, Chapel Hill.
  • Fredericksen RJ; Department of Medicine, University of Washington, Seattle.
  • Kahana S; National Institute on Drug Abuse, Bethesda, Maryland.
  • Kitahata MM; Department of Medicine, University of Washington, Seattle.
  • Kronmal R; Department of Biostatistics, University of Washington, Collaborative Health Studies Coordinating Center, Seattle.
  • Kuo I; Department of Epidemiology, George Washington University, Washington, DC.
  • Kurth A; School of Nursing, Yale University School of Medicine, New Haven, Connecticut.
  • Mathews WC; Department of Medicine, University of California-San Diego, UCSD Medical Center.
  • Mayer KH; Harvard Medical School, Fenway Institute, Boston, Maryland.
  • Moore RD; Department of Medicine, Johns Hopkins University, Baltimore, Maryland.
  • Mugavero MJ; Department of Medicine, University of Alabama-Birmingham.
  • Ouellet LJ; University of Illinois-Chicago.
  • Quan VM; Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Saag MS; Department of Medicine, University of Alabama-Birmingham.
  • Simoni JM; Department of Psychology, University of Washington, Seattle.
  • Springer S; Department of Medicine, Yale University School of Medicine, New Haven, Connecticut.
  • Strand L; Department of Biostatistics, University of Washington, Collaborative Health Studies Coordinating Center, Seattle.
  • Taxman F; Department of Criminology, George Mason University, Fairfax, Virginia.
  • Young JD; University of Illinois-Chicago.
  • Crane HM; Department of Medicine, University of Washington, Seattle.
Clin Infect Dis ; 70(5): 867-874, 2020 02 14.
Article em En | MEDLINE | ID: mdl-30994900
ABSTRACT

BACKGROUND:

Substance use is common among people living with human immunodeficiency virus (PLWH) and a barrier to achieving viral suppression. Among PLWH who report illicit drug use, we evaluated associations between HIV viral load (VL) and reduced use of illicit opioids, methamphetamine/crystal, cocaine/crack, and marijuana, regardless of whether or not abstinence was achieved.

METHODS:

This was a longitudinal cohort study of PLWH from 7 HIV clinics or 4 clinical studies. We used joint longitudinal and survival models to examine the impact of decreasing drug use and of abstinence for each drug on viral suppression. We repeated analyses using linear mixed models to examine associations between change in frequency of drug use and VL.

RESULTS:

The number of PLWH who were using each drug at baseline ranged from n = 568 (illicit opioids) to n = 4272 (marijuana). Abstinence was associated with higher odds of viral suppression (odds ratio [OR], 1.4-2.2) and lower relative VL (ranging from 21% to 42% by drug) for all 4 drug categories. Reducing frequency of illicit opioid or methamphetamine/crystal use without abstinence was associated with VL suppression (OR, 2.2, 1.6, respectively). Reducing frequency of illicit opioid or methamphetamine/crystal use without abstinence was associated with lower relative VL (47%, 38%, respectively).

CONCLUSIONS:

Abstinence was associated with viral suppression. In addition, reducing use of illicit opioids or methamphetamine/crystal, even without abstinence, was also associated with viral suppression. Our findings highlight the impact of reducing substance use, even when abstinence is not achieved, and the potential benefits of medications, behavioral interventions, and harm-reduction interventions.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Drogas Ilícitas / Infecções por HIV / Transtornos Relacionados ao Uso de Substâncias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Drogas Ilícitas / Infecções por HIV / Transtornos Relacionados ao Uso de Substâncias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article